NAS:ESPR () Also Trade In: Germany UK

Esperion Therapeutics Inc $ 38.53 -0.04 (-0.1%)

Volume:
172,962
Avg Vol (1m):
635,248
Market Cap $:
1.07 Bil
Enterprise Value $:
915.18 Mil
P/E (TTM):
0.00
P/B:
0.00
Warning! GuruFocus has detected 5 Severe warning signs with ESPR. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

Financial Strength

2/10
Current Vs Industry Vs History
Cash-To-Debt 27.93
Equity-to-Asset -0.28
Debt-to-Equity -0.11
Debt-to-EBITDA -0.02
N/A
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.16
DISTRESS
GREY
SAFE
Beneish M-Score -16.51
Not Manipulator
Manipulator
WACC vs ROIC
ROIC -2756.87 %
WACC 9.05 %

Profitability Rank

Current Vs Industry Vs History
Operating Margin % -5318.2
Net Margin % -5492.02
ROE % -383.57
ROA % -109.99
ROC (Joel Greenblatt) % -8839.74
3-Year EBITDA Growth Rate 0.2
3-Year EPS without NRI Growth Rate -2.5

Valuation Rank

Current Vs Industry Vs History
PS Ratio 220.75
EV-to-EBIT -3.63
N/A
EV-to-EBITDA -3.64
N/A
EV-to-Revenue 191.26
Current Ratio 2.35
Quick Ratio 2.33
Days Inventory 21676.29
Days Payable 177955.16

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.8

Valuation & Return

Current Vs Industry Vs History
Earnings Yield (Greenblatt) % -27.51